STING1 and neoplasm: Furthermore, the STING agonist was released over time at the tumor site, transforming the tumor bed into a “self‐vaccine site”.[107] Nevertheless, the device needs to be implanted in combination with cytoreductive surgery and additional research is required to investigate the impact on metastasis.